Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353529
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-03-26
Brief Title:
Sphenopalatine Ganglion Block for Postop Pain Management
Sponsor:
Hamilton Health Sciences Corporation
Organization:
Hamilton Health Sciences Corporation
Study Overview
Official Title:
Effect of Sphenopalatine Ganglion Block With Bupivacaine on Postoperative Pain in Patients Undergoing Endoscopic Pituitary Adenoma Resection
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SPGB
Brief Summary:
To assess the benefit of using an additional nerve block during minimally invasive pituitary surgery to improve pain management after surgery The medication Bupivacaine or a placebo saline will be injected during surgery and patients will be asked about their level of pain at multiple time points in the first 24 hours following surgery The aim is to improve patient outcomes and reduce the need for pain medication after surgery
Detailed Description:
To further improve the quality of the early postoperative course the investigators propose the use of the sphenopalatine ganglion SPG block SPGB for pain management in the context of an enhanced recovery after surgery ERAS protocol for minimally invasive MIS endoscopic transsphenoidal pituitary surgery The SPG is the main sensory innervation to the nasal mucosa and several studies have shown the analgesic efficacy of SPGB following sinus surgery and showed positive results for endoscopic sinus surgery However there is limited research on the use of SPGB in the context of pituitary surgery
In this randomized placebo-controlled trial the investigators aim to assess the benefit of SPGB with bupivacaine in addition to multimodal general anesthesia on pain management after MIS pituitary surgery The results of the trial will provide valuable insights into the potential benefits of SPGB and its optimal use for pituitary surgery
In this randomized placebo-controlled trial the investigators aim to assess the benefit of SPGB with bupivacaine in addition to multimodal general anesthesia on pain management after MIS pituitary surgery The results of the trial will provide valuable insights into the potential benefits of SPGB and its optimal use for pituitary surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None